Applications of gene therapy for HIV and hepatitis B and C virus infections

Infections in Medicine

Volumn 13, Issue 9, 1996, Pages 817-823

  Mamounas, Michael ^a   Yu, Mang ^a  

^a Immusol Inc   (United States)

Author keywords

Gene therapy; Hepatitis B virus; Hepatitis C virus; Human immunodeficiency virus (HIV); Influenza

Indexed keywords

EID: 1842327238     PISSN: 07496524     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Baltimore D: Gene therapy: intracellular immunization. Nature 335:395-396, 1988.
2. Yu M: Gene therapy for HIV/AIDS. The AIDS Reader Sept/Oct:145-148, 1994.
3. Gilboa E, Smith C: Gene therapy for infectious diseases: the AIDS model. Trends Genet 10:139-144, 1994.
4. Ho D, Neumann AU, Perelson AS, et al: Rapid turnover of plasma virions and CD4 lymphocytes in HIV infection. Nature 371:123-126, 1995.
5. Wei X, Ghosh SK, Taylor, ME, et al: Viral dynamics in human immunodeficiency virus type-1 infection. Nature 371: 117-122, 1995.
6. Woffendin C, Yang Z-Y, Udaydumar, Xu U et al: Nonviral and viral delivery of a human immunodeficiency virus protective gene in primary human T cells. Proc Natl Acad Sci U S A 91:11581-11585, 1994.
7. Su Y, Waldemar P, Pitha PM: Inhibition of human immunodeficiency virus type-1 replication by a Tat-activated, transduced interferon gene: targeted expression to human immunodeficiency virus type-1-infected cells. J Virol 69:110-121, 1995.
8. Lee SW, Gallardo HF, Gilboa E, et al: Inhibition of human immunodeficiency virus type-1 in human T cells by a potent rev response element decoy consisting of the 13-nucleotide minimal revbinding domain. J Virol 68:8254-8264, 1994.
9. Lisziewicz J, Sun D, Trapnell B, et al: An autoregulated dual-function anti-fat gene for human immunodeficiency virustype-1 gene therapy. J Virol 69:206-212, 1995.
10. Leavitt MC, Yu M, Yamada O, et al: Transfer of a anti-HIV ribozyme gene intoprimary human lymphocytes. Hum Gene Ther 5:1115-1120, 1994.
11. Yu M, Leavitt MC, Maruyama M, et al: Intracellular immunization of human fetal cord blood stem/progenitor cells with a ribozyme against human immunodeficiency virus type-1. Proc Natl Acad Sci U S A 92(3):699-703, 1995.
12. Yu M, Poeschla E, Yamada O, et al: In vitro and in vivo characterization of a second functional hair-pin ribozyme against HIV-1. Virology 206:381-386, 1995.
13. Szmuness W, Stevens CE, Harley EJ, et al. Hepatitis B vaccine: demonstration of efficacy in a controlled clinical trial in a high-risk population in the United States. N Engl J Med 303:833-841, 1980.
14. Scolnick EM, Mclean AA, West DJ, et al: Clinical evaluation in healthy adults of a hepatitis-B vaccine made by recombinant DNA. JAMA 251:2812-2815, 1984.
15. Farci P, Alter HJ, Wong D, et al: A long-term study of hepatitis-C virus replication in non-A, non-B hepatitis. N Engl J Med 325:98-104, 1991.
16. Abe K, Ihnchauspe G, Shikata T, et al: Three different patterns of hepatitis-C virus infection in chimpanzees. Hepatology 15:690-695, 1992.
17. Aach RD, Stevens CE, Hollinger FB, et al: Hepatitis C virus infection in post-transfusion hepatitis: An analysis with first- and second-generation assays. N Engl J Med 325:1325-1329, 1991.
18. Alter MJ, Margolis HS, Krawczyniski K, et al: The natural history of community-acquired hepatitis-C in the United States. N Engl J Med 327:1899-1905, 1992.
19. Ogata N, Alter HJ, Miller RH, et al: Nucleotide sequence and mutation rate of the H strain of hepatitis-C virus. Proc Natl Acad Sci USA 88:3392-3396, 1991.
20. Okamaoto H, Kojima M, Odada SI, et al: Genetic drift of hepatitis-C virus during an 8.2 year infection in a chimpanzee: variability and stability. Virology 190:891-899, 1992.
21. Kato N, Seika H, Ootsuyama Y, et al: Humoral immune response to hypervariable region-1 of the putative envelope Glycoprotein (gp70) of hepatitis-C virus. J Virol 67:3923-3930, 1993.
22. Martell M, Esteban JI, Quer J, et al: Hepatitis-C virus (HCV) circulates as a population of different but closely related genomes: Quasispecies nature of HCV genome distribution. J Virol 66:3225-3229, 1992.
23. Weiner AJ, Thaler MM, Crawford K, et al: A unique, predominant hepatitis-C virus variant found in an infant born to a mother with multiple variants. J Virol 67:4365-4368, 1993.
24. Farci P, Alter HJ, Govindarajan S, et al: Lack of protective immunity against re-infection with hepatitis-C virus. Science 258:135-140, 1992.
25. Prince AM, Brotman B, Huima T, et al: Immunity in hepatitis-C infection. J Infect Dis 165:438-443, 1992.
26. Davis GU Balart LA, Schiff ER, et al: Treatment of chronic hepatitis-C with recombinant interferon alfa: a multicenter randomized, controlled trial. N Engl J Med 321:1501-1506, 1989.
27. Di Bisceglie AM, Martin P, Kassianides C, et al: Recombinant interferon-alfa therapy for chronic hepatitis-C: a randomized, double-blind, placebo-controlled trial. N Engl J Med 321:1506-1510, 1989.
28. Saez-Royuela F, Porres JC, Moreno A, et al: High doses of recombinant alpha-interferon or gamma-interferon for chronic hepatitis-C: A randomized, controlled trial. Hepatology 13:327-331, 1991.
29. Perillo RP: Potential importance of the sexual transmission of non-A, non-B hepatitis. Hepatology 13:805-808, 1991.
30. Tuttleman JS, Pugh JC, Summers JW: In vitro experimental infection of primary duck hepatocytes with duck hepatitis-B virus. J Virol 58:17-28, 1986.
31. Tiollais P, Pourcel C, Dejean A: The hepatitis-B virus. Nature 317:489-495, 1985.
32. Yoo BY, Selby MJ, Suh BS, et al: Transfection of a human liver cell line (Hu&H) with HCV RNA and establishment of a long-term culture persistently infected with HCV, in Nishioka K, Suzuki H, Mishiro S, et al (eds): Proceedings of the 1993 International Symposium on Viral Hepatitis and Liver Disease. Tokyo, Springer-Verlag, 1994.
33. Jacob JR, Burk KH, Eichberg JW, et al: Expression of infectious viral particles by primary chimpanzee hepatocytes isolated during the acute phase of non-A, non-B hepatitis. J Infect Dis 161:1121-1127, 1990.
34. Shimizu YK, Iwamoto A, Hijikata M, et al: Evidence for in vitro replication of hepatitis-C virus genome in a human T-cell line. Proc Natl Acad Sci U S A 89:5477-5481, 1992.
35. Weizsacker FV, Hubert BE, Wands JR: Cleavage of hepatitis-B virus by three ribozymes transcribed from a single DNA template. Biochem Biophys Res Commun 189:743-748, 1992.
36. Wu GY, Wu CH: Specific inhibition of hepatitis-B viral gene expression in vitro by targeted antisense oligonucleotides. J Biol Chem 267:12436-12439, 1992.
37. Curiel DT: Adenovirus facilitation of molecular conjugate-mediated gene transfer. Prog Med Virol 40:1-18, 1993.
38. Cristiano RJ, Smith LC, Kay MA, et al: Hepatic gene therapy: efficient gene delivery and expression in primary hepatocytes utilizing a conjugated adenovirus-DNA complex. Proc Natl Acad Sci U S A 90(24):11548-11552, 1993.
39. Cristiano RJ, Smith LC, Woo SL: Hepatic gene therapy: Adenovirus enhancement of receptor-mediated gene delivery and expression in primary hepatocytes. Proc Natl Acad Sci U S A 90:2122-2126, 1993.
40. Wolf J, Malign R, Williams P, et al: Direct gene transfer into mouse muscle in vivo. Science 247:1465-1468, 1990.
41. Ulmer JB, Donnelly JJ, Parker SE, et al: Heterologous protection against influenza by injection of DNA encoding a viral protein. Science 259:1745-1749, 1993.